Where is the live CopyMark page for USPTO serial 74176862?

The live record is at https://getcopymark.com/trademark/74176862. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns REDI-SCRIPT?

According to the public USPTO record for serial number 74176862, the listed owner(s) include: PD-Rx Pharmaceuticals Inc..

What is USPTO serial number 74176862?

Serial number 74176862 is the USPTO application identifier for the mark REDI-SCRIPT. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover REDI-SCRIPT?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

USPTO serial 74176862

REDI-SCRIPT

Q: What is the current status of REDI-SCRIPT?

REDI-SCRIPT (74176862) currently shows USPTO status code 614 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Reviewed by CopyMark Law Group

Status 614

Filing date: Jun 17, 1991
Status date: Dec 28, 1993
Registration date: —
Examiner: WELLS, KELLEY L
Law office: FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REDI-SCRIPT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

PD-Rx Pharmaceuticals Inc.
Oklahoma City, OK
Other trademarks owned by PD-Rx Pharmaceuticals Inc.

Goods and services

Class	Description	Status	First use
005	unit of use packaging for pharmaceuticals; tablets, capsules, liquids, suppositories, lozenges, troches, perles caplets	ABANDONED	Apr 1, 1991

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 22, 1993	PETD	PETITION TO REVIVE-DENIED	—
Aug 10, 1993	PILM	PETITION INQUIRY LETTER ISSUED	—
Jul 21, 1992	PETR	PETITION TO REVIVE-RECEIVED	—
Jun 8, 1992	ABN2	ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 10, 1991	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 23, 1991	DOCK	ASSIGNED TO EXAMINER	—
Sep 17, 1991	DOCK	ASSIGNED TO EXAMINER	—